RecruitingPhase 1NCT05729932

Cannabis and Opioid Use Disorder

Cannabis Modulation of Outcomes Related to Opioid Use Disorder: Opioid Withdrawal, Abuse Potential and Safety

Sponsor

University of Kentucky

Enrollment

15 participants

Start Date

Sep 10, 2024

Study Type

INTERVENTIONAL

Conditions

Opioid-use Disorder

Summary

This study plans to enroll participants with opioid use disorder who are not currently seeking treatment to assess the effects of cannabis on opioid withdrawal and other related outcomes.

Eligibility

Min Age: 18 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Inhaled vaporized cannabis and a drug called Intransal opioid for people with opioid-use disorder. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 55 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.